List of insiders holdings for Cullinan Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | GADICKE ANSBERT Former Director Director 10% Owner | 2023-02-10 16:26:45 | 595,489 7,648,268 | 8,243,757 | Form 5 |
| 2 | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner | 2021-08-25 19:42:33 | 7,805,483 0 | 7,805,483 | Form 4 |
| 3 | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner | 2021-09-20 17:31:24 | 7,648,268 0 | 7,648,268 | Form 4 |
| 4 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2024-11-14 16:24:39 | 5,796,433 0 | 5,796,433 | Form 13G |
| 5 | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner | 2024-02-14 16:59:56 | 2,177,461 0 | 2,177,461 | Form 13G |
| 6 | F2 Bioscience I 2017 Ltd Jovan-Embiricos Morana 10% Owner | 2024-02-14 16:59:56 | 2,177,461 0 | 2,177,461 | Form 13G |
| 7 | F2 Vision SCS Jovan-Embiricos Morana 10% Owner | 2024-02-14 16:59:56 | 2,177,461 0 | 2,177,461 | Form 13G |
| 8 | Hughes Owen President and CEO | 2021-01-14 17:30:09 | 506,226 0 | 506,226 | Form 4 |
| 9 | Baeuerle Patrick Chief Scientific Officer | 2023-02-21 18:53:33 | 153,000 341,434 | 494,434 | Form 4 |
| 10 | AHMED NADIM President and CEO | 2025-02-27 17:00:07 | 430,621 0 | 430,621 | Form 4 |
| 11 | Savill Corrine Chief Business Officer | 2025-02-21 18:00:09 | 315,990 0 | 315,990 | Form 4 |
| 12 | Trigilio Jeffrey Chief Financial Officer | 2024-02-23 17:00:15 | 233,919 0 | 233,919 | Form 4 |
| 13 | Nguyen Nate Interim PAO and PFO | 2024-04-02 20:50:22 | 224,000 0 | 224,000 | Form 3 |
| 14 | Ebeling Thomas Director | 2024-06-11 18:00:03 | 186,653 0 | 186,653 | Form 4 |
| 15 | Fenton Mary Kay Chief Financial Officer | 2025-02-21 18:00:03 | 180,000 0 | 180,000 | Form 4 |
| 16 | Jones Jeffrey Alan Chief Medical Officer | 2025-02-27 17:00:09 | 174,164 0 | 174,164 | Form 4 |
| 17 | Michaelson Jennifer Chief Scientific Officer | 2025-02-27 17:00:06 | 142,004 0 | 142,004 | Form 4 |
| 18 | SUMER JACQUELYN L Chief Legal Officer | 2025-02-27 17:00:03 | 136,895 0 | 136,895 | Form 4 |
| 19 | Zawel Leigh See Remarks | 2022-02-15 16:47:15 | 134,785 0 | 134,785 | Form 4 |
| 20 | Wigginton Jon Marc Chief Medical Officer | 2021-01-11 17:32:05 | 116,666 0 | 116,666 | Form 4 |
| 21 | Keane Raymond T Chief Legal Officer | 2022-02-15 16:48:52 | 69,124 0 | 69,124 | Form 4 |
| 22 | Martin Anne-Marie Director | 2025-06-16 16:07:18 | 38,513 0 | 38,513 | Form 4 |
| 23 | Meek David D. Director | 2025-06-16 16:09:05 | 38,513 0 | 38,513 | Form 4 |
| 24 | Webster Stephen W Director | 2025-06-16 16:10:34 | 38,513 0 | 38,513 | Form 4 |
| 25 | Rosenberg Anthony Director | 2025-06-16 16:12:11 | 38,513 0 | 38,513 | Form 4 |
| 26 | Ryan David P. Director | 2025-06-16 16:14:54 | 38,513 0 | 38,513 | Form 4 |
| 27 | Thistle Mary Director | 2024-08-09 18:00:03 | 0 0 | 0 | Form 3 |